Diagnostic Value of Combined Detection of Serum Glycosylated Hemoglobin,C-Peptide and Fasting Blood Glucose in Type 2 Diabetes Nephropathy
Objective To explore the value of combined detection of serum glycosylated hemoglobin(HbAlc),C-peptide and fasting blood glucose(FBG)in the diagnosis of type 2 diabetes nephropathy.Methods 90 patients with type 2 diabetes admitted to our hospital from May 2021 to June 2023 were selected and divided into the diabetes nephropathy group(32 cases)and the simple diabetes group(58 cases)according to whether diabetes nephropathy occurred;Another 40 healthy individuals during the same period were selected as the control group.The levels of serum HbAlc,C-peptide,and FBG at admission were compared among three groups.The diagnostic efficiencies of single detection and combined detection of serum HbAlc,C-peptide and FBG for diabetes nephropathy were analyzed.Results The levels of serum HbAlc and FBG in the diabetes nephropathy group,the simple diabetes group and the control group decreased in turn,and the level of serum C-peptide increased in tum(P＜0.05).The A UC of combined detection of serum HbAlc,C-peptide and FBG in the diagnosis of type 2 diabetes nephropathy was 0.893,higher than that of single detection of each index(P＜0.05).Conclusions The levels of serum HbAlc and FBG in patients with type 2 diabetes nephropathy increase abnormally,and the level of serum C-peptide decreases abnormally;The combined detection of serum HbAlc,C-peptide and FBG has high diagnostic value for type 2 diabetes nephropathy.
Glycosylated hemoglobinC-peptideFasting blood glucoseType 2 diabetes nephropathyDiagnostic value
万方数据
维普
